Dec 08, 2021 / 09:00PM GMT
Spencer Israel - Benzinga - Moderator
All right. Let's move on here, and let's bring on Dr. Adam Kaplin, the Chief Scientific Officer of MyMD Pharmaceuticals. There he is. How are we doing today?
Adam Kaplin - MyMD Pharmaceuticals, Inc. - Chief Scientific Officer
Good. How are you, Spencer?
Spencer Israel - Benzinga - Moderator
Doing great, doing great. It's been a minute since we caught up. So good to see you again. I hope your Thanksgiving was well. Let's bring his slides up on the screen, guys. There we go.
And Adam, take it away.
Adam Kaplin - MyMD Pharmaceuticals, Inc. - Chief Scientific Officer
Thanks so much. I also to wanted to make sure that my colleague, Rob, who's the brainchild about all things financial, is hiding in the wings. So he's my fall guy. He's my net, and I never performed without a net.
Spencer Israel - Benzinga - Moderator
He is lurking backstage. Yes, we'll bring him on a little bit.
MyMD Pharmaceuticals Inc at Benzinga Global Small Cap Investor Conference (Virtual) Transcript
Dec 09, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers